Dow Jones Industrial Average Lower as Goldman Wrecks Energy Stocks

Energy stocks are swooning amid Goldman Sachs' price-target cuts

Jan 12, 2015 at 11:38 AM
facebook twitter linkedin


The Dow Jones Industrial Average (INDEXDJX:DJI) popped out of the gate, but quickly succumbed to headwinds as oil dropped to a new five-year low. Weighing on liquid gold was Goldman Sachs' decision to lower its price forecast, which the firm followed with a number of bearish brokerage notes on energy stocks. Meanwhile, all eyes are on Alcoa Inc (NYSE:AA), which will unofficially kick off earnings season after the close. At last check, the DJI was down 47.7 points, or 0.3%, at 17,689.65.

Continue reading for more on today's market -- and don't miss:

  • Why recent options traders are cheering a massive sell-off in this biopharmaceutical stock.
  • Schaeffer's contributor Adam Warner asks an important question: Will 2015 turn into 2008?
  • Plus ... Checking in on the CBOE Volatility Index (VIX), the SPDR S&P 500 ETF Trust (SPY), and other noteworthy stats at midday.

Midday Market Stats

Among the stocks with notable call volume is streaming content provider Sirius XM Holdings Inc. (NASDAQ:SIRI), where the contracts are crossing at nearly nine times the expected intraday rate. The majority of the action has transpired at the at-the-money June 3.50 call, where a block of 34,000 contracts changed hands. While it appears these positions are being initiated, it's unclear whether they're being bought or sold. At last check, SIRI was up 0.1% at $3.54.

For more midday statistics and stocks on the move, head to page 2.

Tiffany & Co. (NYSE:TIF) is among the major decliners on the Big Board today -- down nearly 12% to trade at $91.25 -- after lowering its annual forecast in the wake of a disappointing holiday season. Also hitting on the shares was a price-target cut to $110 from $121 at Sterne Agee, which nonetheless maintained its "buy" rating. On the other hand, Canaccord Genuity upped its price target by $3 to $100, and reiterated its "hold" opinion.

Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) is among the Nasdaq's most impressive gainers, tacking on more than 42% to hover around $22.36. Spurring the stock higher is the firm's agreement to buy privately held OnCore Biopharma Inc. TKMR is now exploring territory not charted since mid-October.

Daily Chart of TKMR Since October 2014

The CBOE Volatility Index (VIX) is up 1.6 points, or 9.2%, at 19.16, after losing ground in last week's trading.

Today's put/call volume ratio on the SPDR S&P 500 ETF Trust (SPY) is 1.71, with puts running ahead of calls. At last check, SPY is down 1.4 points, or 0.7%, at $202.86.

 

Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

 
Best stocks for October and worst stocks for October
 


 


 
Special Offers from Schaeffer's Trading Partners